VIRIDIAN THERAPEUTICS INC's ticker is VRDN and the CUSIP is 92790C104. A total of 139 filers reported holding VIRIDIAN THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.29 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $37,552,550 | -39.2% | 2,448,015 | -5.7% | 0.00% | 0.0% |
| Q2 2023 | $61,774,161 | +14.0% | 2,596,644 | +21.9% | 0.00% | 0.0% |
| Q1 2023 | $54,193,128 | -12.3% | 2,130,233 | +0.7% | 0.00% | -50.0% |
| Q4 2022 | $61,778,974 | +62.2% | 2,114,994 | +13.9% | 0.00% | +100.0% |
| Q3 2022 | $38,083,000 | +133.3% | 1,856,800 | +31.6% | 0.00% | – |
| Q2 2022 | $16,324,000 | -6.1% | 1,410,902 | +50.0% | 0.00% | – |
| Q1 2022 | $17,391,000 | -5.0% | 940,577 | +1.6% | 0.00% | – |
| Q4 2021 | $18,301,000 | +140.8% | 925,676 | +100.4% | 0.00% | – |
| Q3 2021 | $7,599,000 | +17.3% | 461,912 | +30.5% | 0.00% | – |
| Q2 2021 | $6,476,000 | +130.1% | 354,066 | +110.1% | 0.00% | – |
| Q1 2021 | $2,815,000 | – | 168,518 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VR Adviser, LLC | 2,699,865 | $78,863,057 | 13.28% |
| COMMODORE CAPITAL LP | 2,020,166 | $59,009 | 8.89% |
| ACUTA CAPITAL PARTNERS, LLC | 396,500 | $11,581,765 | 7.13% |
| Fairmount Funds Management LLC | 1,369,623 | $40,006,688 | 6.35% |
| Paradigm Biocapital Advisors LP | 1,751,167 | $51,151,588 | 6.00% |
| Vivo Capital, LLC | 1,678,207 | $49,020 | 5.64% |
| TCG Crossover Management, LLC | 983,610 | $28,731,248 | 5.07% |
| Kynam Capital Management, LP | 1,034,697 | $30,223,499 | 4.64% |
| Octagon Capital Advisors LP | 824,200 | $24,074,882 | 3.75% |
| Logos Global Management LP | 1,000,000 | $29,210,000 | 3.42% |